{
    "title": "Eisai shares plunge 10% in Tokyo after report of death in Alzheimer's trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11479799/Eisai-shares-plunge-10-Tokyo-report-death-Alzheimers-trial.html",
    "date": "2022-11-29",
    "keywords": [
        "biogen",
        "eisai",
        "report",
        "trial",
        "drug",
        "comment",
        "tokyo",
        "woman",
        "request",
        "information",
        "nov",
        "drugmaker",
        "co",
        "plunge",
        "year",
        "tuesday",
        "companys",
        "treatment",
        "partner",
        "inc",
        "brain",
        "haemorrhage",
        "research",
        "paper",
        "publisher",
        "scienceorg",
        "sunday",
        "fatality",
        "death",
        "man",
        "june",
        "health",
        "journal",
        "stat",
        "benchmark",
        "nikkei",
        "index",
        "morning",
        "session",
        "monday",
        "response",
        "roller",
        "coaster",
        "battle",
        "aduhelm",
        "approval",
        "food",
        "administration",
        "use",
        "price",
        "effectiveness",
        "lecanemab",
        "cognitive",
        "decline",
        "september",
        "reporting",
        "swift",
        "raghav",
        "mahobe",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "cynthia",
        "osterman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}